• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Wellcentive Unveils Volume to Value-based Care Calculator for Providers

by HITC Staff 05/06/2016 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Wellcentive_logo

Wellcentive, an Atlanta-based provider of value-based care solutions has launched a free tool to calculate the real cost of delaying the shift from public and private payer volume to value-based care (VBC) and reimbursement. The tool called the Cost of Inaction calculator helps organizations estimate the impact, based on national benchmark data for health services and the organization-specific data users submit, of delaying effective implementation and management of VBC practices.

Why Now Is The Time for Value-based Care

Private payers have historically followed Medicare’s lead regarding new payment models, and The Centers for Medicare & Medicaid Services (CMS) continues to roll out VBC initiatives with significant incentives. There is not just an opportunity cost for those who delay, however – payers are also imposing penalties and driving providers toward more financial risk.

As an example, a physician group with $200 million in revenue, 350 providers, and a payer mix of 30 percent Medicare and 30 percent commercial will experience a cost of inaction, using a conservative analysis, of $20 million over five years.

Value-based care is rapidly becoming both a catalyst for change and the industry standard driven by:

– The Medicare Access & CHIP Reauthorization Act of 2015 (MACRA) proposed rule has been issued, which emphasizes advanced payment models, expanded quality and registry reporting and population health management.

– Bundled payment programs – also included as MACRA APMs – are expanding among payers.

– CMS recently announced the Comprehensive Primary Care Plus (CPC+) payment model – a MACRA Advanced APM – the agency’s largest multi-payer initiative for value-based primary care. The CPC+ model is schedule to begin implementation in 2017 across up to 20 regions targeting 20,000 physicians and approximately 25 million patients.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: value based reimbursement, Wellcentive

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Virta Health CEO: GLP-1s Didn’t Kill Weight Watchers, Its Broken Model Did

Most-Read

Moving Beyond EHRs: What Lies Ahead for Healthcare Digitization?

AI Agents vs. Chatbots: Understanding Agentic AI’s Role in Healthcare

AI Breakthrough Reveals 2025 AI Breakthrough Award Winners

AI Breakthrough Reveals 2025 AI Breakthrough Award Winners

Healthcare's Big Blind Spot: The Measurement Crisis in Inpatient Psychiatry

Healthcare’s Big Blind Spot: The Measurement Crisis in Inpatient Psychiatry

Lessons Learned from The Change Healthcare Cyberattack, One Year Later

Lessons Learned from The Change Healthcare Cyberattack, One Year Later

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Omada Health Launches "Nutritional Intelligence" with AI Agent OmadaSpark

Omada Health Soars in NASDAQ Debut, Signaling Digital Health IPO Rebound

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |